{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:34:40Z","timestamp":1778589280745,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.eplepsyres.2014.05.008","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T15:15:45Z","timestamp":1400685345000},"page":"1145-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antiepileptic efficacy of lamotrigine in phenobarbital-resistant and -responsive epileptic rats: A pilot study"],"prefix":"10.1016","volume":"108","author":[{"given":"Claudia","family":"Brandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2011.12.014","article-title":"Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy","volume":"234","author":"Bankstahl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0010","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/j.1528-1167.2010.02671.x","article-title":"Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy","volume":"51","author":"Bartmann","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0015","series-title":"Jasper's Basic Mechanisms of the Epilepsies","first-page":"1077","article-title":"Antiepileptogenesis, plasticity of AED targets, drug resistance, and targeting the immature brain","author":"Beck","year":"2012"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2003.09.007","article-title":"Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial","volume":"57","author":"Beghi","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0025","series-title":"Models of Seizures and Epilepsy","first-page":"569","article-title":"Monitoring for seizures in rodents","author":"Bertram","year":"2006"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1528-1167.2007.00980.x","article-title":"Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy","volume":"48","author":"Bethmann","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-1211(03)00114-1","article-title":"Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats","volume":"55","author":"Brandt","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0040","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.0013-9580.2004.16904.x","article-title":"Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus","volume":"45","author":"Brandt","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2014.05.008_bib0045","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/0883073897012001031","article-title":"Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?","volume":"12","author":"Coulter","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0050","series-title":"Models of Seizures and Epilepsy","first-page":"415","article-title":"Kainate-induced status epilepticus: a chronic model of acquired epilepsy","author":"Dudek","year":"2006"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neulet.2011.03.071","article-title":"The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis","volume":"497","author":"Dudek","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0060","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0028-3908(00)00039-3","article-title":"The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats","volume":"39","author":"Ebert","year":"2000","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.eplepsyres.2014.05.008_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2007.00992.x","article-title":"Refractory epilepsy: clinical overview","volume":"48","author":"French","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1528-1167.2011.03391.x","article-title":"Identification of new epilepsy treatments: issues in preclinical methodology","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1528-1157.2002.18101.x","article-title":"Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy","volume":"43","author":"Glien","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2007.03.008","article-title":"Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat","volume":"205","author":"Goffin","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0085","first-page":"354","article-title":"Carbamazepine vs diphenylhydantoin vs their combination in adult epilepsy","volume":"30","author":"Hakkarainen","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0095","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1528-1157.1995.tb01613.x","article-title":"Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs","volume":"36","author":"H\u00f6nack","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0100","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.yebeh.2003.08.033","article-title":"Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy","volume":"4","author":"Kaminow","year":"2003","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2009.12.002","article-title":"Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity","volume":"37","author":"K\u00fccker","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/seiz.2000.0442","article-title":"Epilepsy after the first drug fails: substitution or add-on?","volume":"9","author":"Kwan","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0120","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0130","series-title":"Models of Seizures and Epilepsy","first-page":"551","article-title":"Animal models of drug-refractory epilepsy","author":"L\u00f6scher","year":"2006"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1167.2009.02183.x","article-title":"High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy","volume":"51","author":"L\u00f6scher","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","volume":"52","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for antiepileptic drug discovery and development","volume":"12","author":"L\u00f6scher","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13311-011-0039-z","article-title":"Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice","volume":"8","author":"Maroso","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yebeh.2005.01.008","article-title":"Pharmacological outcomes in newly diagnosed epilepsy","volume":"6","author":"Mohanraj","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0165","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs \u2013 best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood\u2013brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1684\/epd.2012.0532","article-title":"Animal models of drug-resistant epilepsy","volume":"14","author":"Potschka","year":"2012","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuropharm.2010.11.005","article-title":"Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats","volume":"60","author":"Rattka","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2012.09.015","article-title":"The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats","volume":"103","author":"Rattka","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(02)00064-7","article-title":"Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy","volume":"112","author":"Riban","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1535-7511.2008.00272.x","article-title":"Intrinsic severity as a determinant of antiepileptic drug refractoriness","volume":"8","author":"Rogawski","year":"2008","journal-title":"Epilepsy Curr."},{"issue":"Suppl. 2","key":"10.1016\/j.eplepsyres.2014.05.008_bib0210","first-page":"32","article-title":"The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0215","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1528-1167.2012.03541.x","article-title":"Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design","volume":"53","author":"Simonato","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0220","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.0013-9580.2003.32803.x","article-title":"Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH\/NINDS\/AES models II workshop","volume":"44","author":"Stables","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0225","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.nucmedbio.2013.05.008","article-title":"[11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness","volume":"40","author":"Syvanen","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0230","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0920-1211(96)00074-5","article-title":"Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study","volume":"25","author":"Tanganelli","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2014.05.008_bib0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1745-6215-8-34","article-title":"Multiple treatment comparisons in epilepsy monotherapy trials","volume":"8","author":"Tudur Smith","year":"2007","journal-title":"Trials"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121114001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:31:39Z","timestamp":1760275899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121114001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0920121114001405"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.05.008","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic efficacy of lamotrigine in phenobarbital-resistant and -responsive epileptic rats: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}